[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Shinnick, 2013 - Google Patents

Tuberculosis

Shinnick, 2013

Document ID
18323631829115781526
Author
Shinnick T
Publication year

External Links

Snippet

Tuberculosis has plagued mankind since prehistoric times and is still an important source of morbidity and mortality, with particularly devastating effects in developing and tropical countries. Tuberculosis results from an infection with Myeo baeterium tubereu/osis, and the …
Continue reading at books.google.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Similar Documents

Publication Publication Date Title
Saint-Joanis et al. Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases β-lactam susceptibility and virulence
Gao et al. Requirement for kasB in Mycobacterium mycolic acid biosynthesis, cell wall impermeability and intracellular survival: implications for therapy
Forrellad et al. Virulence factors of the Mycobacterium tuberculosis complex
Young et al. Prospects for new interventions in the treatment and prevention of mycobacterial disease
Raynaud et al. Phospholipases C are involved in the virulence of Mycobacterium tuberculosis
Hansen et al. N-glycolylated peptidoglycan contributes to the immunogenicity but not pathogenicity of Mycobacterium tuberculosis
Viljoen et al. A simple and rapid gene disruption strategy in Mycobacterium abscessus: on the design and application of glycopeptidolipid mutants
Chopra et al. New drug targets for Mycobacterium tuberculosis
Makinoshima et al. Site-2 proteases in prokaryotes: regulated intramembrane proteolysis expands to microbial pathogenesis
Ferrell et al. Virulence mechanisms of Mycobacterium abscessus: Current knowledge and implications for vaccine design
Hotter et al. Mycobacterium bovis lipids: virulence and vaccines
Joshi et al. Insights into the molecular determinants involved in Mycobacterium tuberculosis persistence and their therapeutic implications
Shinnick Tuberculosis
EP1981964B1 (en) Mycobacterial seca2 mutants
Khattak et al. Illegitimate recombination: an efficient method for random mutagenesis in Mycobacterium avium subsp. hominissuis
Lagier et al. Identification of genetic loci implicated in the survival of Mycobacterium smegmatis in human mononuclear phagocytes
Heym et al. Mechanisms of drug resistance in Mycobacterium tuberculosis
Ward et al. Transcriptional profiling of Mycobacterium tuberculosis during infection: lessons learned
Hatfull The molecular genetics of Mycobacterium tuberculosis
Bojang Towards identifying intracellular drug targets of Mycobacterium tuberculosis against hit compounds in defined growth media
Xu Molecular mechanisms of drug synergy and persistence in Mycobacterium tuberculosis
Hatfull Mycobacteriophages: pathogenesis and applications
Mahlakwana ​​ CRISPRi mediated investigation of the vulnerability of two essential cell wall biosynthetic gene products in mycobacteria.
Mucugi Molecular targets and mechanisms of action of pyrazinamide in Mycobacterium tuberculosis
Bushura et al. Review on Mycobacterial Metabolic Pathways as Drug Targets